Frontiers Lysosomal Diseases and Neuropsychiatry: Opportunities
Por um escritor misterioso
Descrição
Frontiers Lysosomal Diseases and Neuropsychiatry: Opportunities to Rebalance the Mind
Frontiers NEU1—A Unique Therapeutic Target for Alzheimer's Disease
Gastroenterology Insights, Free Full-Text
Frontiers Dynamics of a model for the degradation mechanism of aggregated α-synuclein in Parkinson's disease
Tubulin deacetylase NDST3 modulates lysosomal acidification: Implications in neurological diseases - Tang - 2022 - BioEssays - Wiley Online Library
Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS - The Lancet Child & Adolescent Health
Frontiers CRISPR-Cas9 Knock-In of T513M and G41S Mutations in the Murine β–Galactosyl-Ceramidase Gene Re-capitulates Early-Onset and Adult-Onset Forms of Krabbe Disease
Neuronopathic Lysosomal Storage Diseases - Specific Neuronal Characteristics and Therapeutic Approaches
FDA approved compounds for lysosomal storage disorders, endpoints and
Toward discovering a novel family of peptides targeting neuroinflammatory states of brain microglia and astrocytes - Koss - Journal of Neurochemistry - Wiley Online Library
Approved enzyme replacement therapies for lysosomal storage disorders
Clarifying lysosomal storage diseases: Trends in Neurosciences
The Possible Involvement of Autophagy in Neuropsychiatric Disorders and Their Treatment
Lipid metabolic perturbation is an early-onset phenotype in adult spinster mutants: a Drosophila model for lysosomal storage disorders
Frontiers The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?
de
por adulto (o preço varia de acordo com o tamanho do grupo)
